Almotriptan
Axert (almotriptan) is a small molecule pharmaceutical. Almotriptan was first approved as Axert on 2001-05-07. It is used to treat migraine disorders in the USA. It is known to target 5-hydroxytryptamine receptor 1B and 5-hydroxytryptamine receptor 1D.
| Trade Name | Axert |
|---|---|
| Common Name | Almotriptan |
| Indication | migraine disorders |
| Drug Class | Antimigraine agents (5-HT1 receptor agonists),sumatriptan derivatives |
